Jason Baum - Oct 2, 2024 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role: Chief Scientific Officer
Signature: /s/ Douglas E. Onsi, as attorney-in-fact for Jason Baum
Stock symbol: LPTX
Transactions as of: Oct 2, 2024
Transactions value $: $0
Form type: 4
Date filed: 10/4/2024, 05:23 PM
Previous filing: Jan 31, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LPTX	Employee Stock Option (Right to Buy)	Award	$0	+85K		$0.00	85K	Oct 2, 2024	Common Stock	85K	$2.45	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of October 2, 2024.

Content

The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of October 2, 2024.